Fidelity Disruptors ETF

FDIF

Börsenwert 104 Mio. $

BOSTON--(BUSINESS WIRE)--Fidelity Investments® today announced the upcoming liquidation of five exchange-traded funds (ETFs): Fidelity Disruptive Finance ETF (FDFF), Fidelity Disruptive Medicine ETF (FMED), Fidelity Disruptors ETF (FDIF), Fidelity Metaverse ETF (FMET) and Fidelity Real Estate Investment ETF (FPRO). November 12, 2026, is expected to be the last full day of trading for FDFF, FMED, FDIF, and FMET on Nasdaq, and FPRO on Cboe. Shareholders may sell their ETF shares until market clos.

In a market environment fraught with sticky inflation, rapid AI integration, and shifting geopolitical landscapes, growth strategies are being tested. Investors seeking exposure to the next generation of industry leaders in various business sectors should take a closer look at the Fidelity Disruptors ETF (FDIF).

Fidelity Investment's suite of disruptive ETFs are designed to capture growth opportunities arising from groundbreaking innovation and transformative technologies.

FDIF offers exposure to all five Fidelity Disruptive ETFs, making it suitable for investors who don't want to pick individual winners. The fund has underperformed broad market benchmarks and most underlying ETFs, raising concerns about its effectiveness as a core holding. FDIF only makes sense for those seeking convenience, as it doesn't deliver superior returns or risk-adjusted performance compared to broad index funds.

Thematic investing continues to garner attention at the midyear point on sustained artificial intelligence interest. For advisors and investors looking to diversify their thematic holdings, the Disruptive ETF suite from Fidelity offers strategies cutting across several sectors.